Found: 69
Select item for more details and to access through your institution.
Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 8, p. 1469, doi. 10.1111/imj.16100
- By:
- Publication type:
- Article
The importance of frailty assessment in multiple myeloma: a position statement from the Myeloma Scientific Advisory Group to Myeloma Australia.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 5, p. 819, doi. 10.1111/imj.16049
- By:
- Publication type:
- Article
Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 2, p. 166, doi. 10.1159/000527631
- By:
- Publication type:
- Article
Safety, Feasibility, and Efficacy of Exercise Interventions for People With Multiple Myeloma: A Systematic Review.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00520-7
- By:
- Publication type:
- Article
The second revision of the International Staging System (R2‐ISS) stratifies progression‐free and overall survival in multiple myeloma: Real world data results in an Australian and New Zealand Population.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. e17, doi. 10.1111/bjh.18536
- By:
- Publication type:
- Article
Current approaches to the diagnosis and management of amyloidosis.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 12, p. 2046, doi. 10.1111/imj.15974
- By:
- Publication type:
- Article
Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 6, p. 988, doi. 10.1111/bjh.18233
- By:
- Publication type:
- Article
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 5, p. 830, doi. 10.1111/bjh.18324
- By:
- Publication type:
- Article
Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 719, doi. 10.1002/ajh.26536
- By:
- Publication type:
- Article
An Individualized Exercise Intervention for People with Multiple Myeloma—Study Protocol of a Randomized Waitlist-Controlled Trial.
- Published in:
- Current Oncology, 2022, v. 29, n. 2, p. 901, doi. 10.3390/curroncol29020077
- By:
- Publication type:
- Article
P-116: The impact of SLiM criteria in myeloma in a real-life population: clinical characteristics, treatment and outcome from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S98, doi. 10.1016/S2152-2650(21)02243-6
- By:
- Publication type:
- Article
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant‐ineligible patients with myeloma who are treated with bortezomib‐based induction.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 4, p. 497, doi. 10.1111/ejh.13677
- By:
- Publication type:
- Article
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 10, p. 1707, doi. 10.1111/imj.15457
- By:
- Publication type:
- Article
The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
- Published in:
- 2021
- By:
- Publication type:
- journal article
SIRPα Suppresses Response to Therapeutic Antibodies by Nurse Like Cells From Chronic Lymphocytic Leukemia Patients.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.610523
- By:
- Publication type:
- Article
The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemia.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00401-3
- By:
- Publication type:
- Article
Report of the Survey Conducted by RCPAQAP on Current Practices for Beta-Migrating Paraprotein Reporting.
- Published in:
- Clinical Biochemist Reviews, 2021, v. 42, n. 1, p. 11, doi. 10.33176/AACB-21-00001
- By:
- Publication type:
- Article
Catheter‐related thrombosis incidence and risk factors in adult cancer patients with central venous access devices.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 12, p. 1475, doi. 10.1111/imj.14780
- By:
- Publication type:
- Article
Physical Activity in People with Multiple Myeloma: Associated Factors and Exercise Program Preferences.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3277, doi. 10.3390/jcm9103277
- By:
- Publication type:
- Article
Bortezomib use and outcomes for the treatment of multiple myeloma.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 9, p. 1059, doi. 10.1111/imj.14886
- By:
- Publication type:
- Article
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0227455
- By:
- Publication type:
- Article
Pacific Islanders with multiple myeloma are younger and have inferior survival when compared to other ethnicities: a study from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e213, doi. 10.1016/j.clml.2019.09.354
- By:
- Publication type:
- Article
Development of an Individualized, Supervised Exercise Intervention as Standard Care for Patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e213, doi. 10.1016/j.clml.2019.09.355
- By:
- Publication type:
- Article
Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e225, doi. 10.1016/j.clml.2019.09.375
- By:
- Publication type:
- Article
Receiving four or less cycles of therapy predicts poor survival in newly diagnosed transplant ineligible patients with myeloma who are treated with bortezomib-based induction.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e233, doi. 10.1016/j.clml.2019.09.388
- By:
- Publication type:
- Article
Significantly improved relative survival of patients with myeloma in Queensland with treatment advances.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e233, doi. 10.1016/j.clml.2019.09.387
- By:
- Publication type:
- Article
Carfilzomib, Thalidomide and Dexamethasone (KTd) is safe and effective in RRMM: interim analysis of the single arm, multicentre phase II ALLG MM018/AMN002 study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e274, doi. 10.1016/j.clml.2019.09.452
- By:
- Publication type:
- Article
The epidemiology of amyloidosis in Queensland, Australia.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. 829, doi. 10.1111/bjh.16000
- By:
- Publication type:
- Article
Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Response to article by Caponi et al. about serum free light chains.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Response to Letter to the Editor about immunochemical measurement of urine free light chains.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Proposed Addendum to 2012 Recommendations for Standardised Reporting of Protein Electrophoresis in Australia and New Zealand.
- Published in:
- Clinical Biochemist Reviews, 2019, v. 40, n. 1, p. 23
- By:
- Publication type:
- Article
Paraprotein Sample Exchange in Australia and New Zealand -- 2018.
- Published in:
- Clinical Biochemist Reviews, 2019, v. 40, n. 1, p. 43
- By:
- Publication type:
- Article
Relative survival of patients with lymphoma in Queensland according to histological subtype.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Considerations for pre‐transfusion immunohaematology testing in patients receiving the anti‐CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.
- Published in:
- Internal Medicine Journal, 2018, v. 48, n. 2, p. 210, doi. 10.1111/imj.13707
- By:
- Publication type:
- Article
Bisphosphonate guidelines for treatment and prevention of myeloma bone disease.
- Published in:
- Internal Medicine Journal, 2017, v. 47, n. 8, p. 938, doi. 10.1111/imj.13502
- By:
- Publication type:
- Article
Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting.
- Published in:
- International Journal of Clinical Pharmacy, 2017, v. 39, n. 4, p. 836, doi. 10.1007/s11096-017-0480-0
- By:
- Publication type:
- Article
Monitoring of light chain myeloma - time for a change.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 328, doi. 10.1111/bjh.14063
- By:
- Publication type:
- Article
Rates of Upfront Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM): A report from the MRDR.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e30, doi. 10.1016/j.clml.2017.03.052
- By:
- Publication type:
- Article
Combination Bone Marrow Imaging Using PET-MRI in Plasma Cell Dyscrasias: Correlation With Prognostic Laboratory Values and Clinicopathological Diagnosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e45, doi. 10.1016/j.clml.2017.03.081
- By:
- Publication type:
- Article
Maturing Data from the Australia and New Zealand Myeloma and Related Diseases Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e105, doi. 10.1016/j.clml.2017.03.190
- By:
- Publication type:
- Article
Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome.
- Published in:
- Nephrology, 2017, v. 22, p. 15, doi. 10.1111/nep.12934
- By:
- Publication type:
- Article
Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
- Published in:
- Internal Medicine Journal, 2017, v. 47, n. 1, p. 35, doi. 10.1111/imj.13311
- By:
- Publication type:
- Article
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry.
- Published in:
- BMC Medical Research Methodology, 2016, v. 16, p. 1, doi. 10.1186/s12874-016-0250-z
- By:
- Publication type:
- Article
Cardiac Amyloid Imaging with <sup>18</sup>F-Florbetaben PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 11, p. 1733, doi. 10.2967/jnumed.115.169870
- By:
- Publication type:
- Article
Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
- Published in:
- Clinical Proteomics, 2016, v. 13, p. 1, doi. 10.1186/s12014-016-9133-x
- By:
- Publication type:
- Article